Nevro Investor Relations Material
Latest events
Q3 2024
Nevro
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nevro Corp
Access all reports
Nevro Corp. is a medical device company specializing in developing and commercializing solutions for the treatment of chronic pain. The company’s primary product is the Senza spinal cord stimulation (SCS) system, which utilizes proprietary high-frequency technology to manage pain without causing paresthesia. The company is headquartered in Redwood City, California, and its shares are listed on the NYSE.
Key slides for Nevro Corp
Q2 2024
Nevro Corp
Q3 2024
Nevro Corp
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NVRO
Country
🇺🇸 United States